Silexion - Rasio nilai perusahaan marang dodolan SLXN

Simbol resmi perusahaan Silexion Therapeutics Corp. (SLXN)

Silexion Therapeutics Corp (SLXN) is pursuing expansion within the pancreatic cancer RNA therapy segment, and consequently, the EV/Revenue multiple currently reflects the business development dynamics, with the value holding at 0.00. Intense competition in the development of drugs targeting KRAS mutations remains the primary challenge. Process stability is ensured through diversified component supply channels and long-term partnerships with laboratories.

Silexion Therapeutics (SLXN): Nilai perusahaan marang pendapatan saka 23.11.2025 nganti 21.11.2026

Silexion Therapeutics - rincian analitis lan metrik utama (SLXN)

Pambiji fundamental perusahaan:SLXN, Silexion
Produk sing diprodhuksi silexion.com

This indicator determines the market value of the business inclusive of net debt, comparing it to sales volume to assess the efficiency of revenue capitalization. By analyzing the EV to total revenue multiple on the GURU.Markets platform, an investor evaluates the asset value of Silexion Therapeutics Corp (SLXN) through the prism of its success in developing innovative RNA drugs to combat hard-to-treat forms of oncology.

Analisis pesaing

Multiplikator nilai perusahaan marang pendapatan Incyte Corporation|HCM (HUTCHMED Corp) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Nuvation Pharma NUVB|Nilai perusahaan marang pendapatan DAWN|Multiplikator nilai perusahaan marang pendapatan Monopar Therapeutics MNPR|Nilai perusahaan marang pendapatan INBX (Inhibrx Biosciences)|IMAB (I-Mab Inc.) - Nilai bisnis marang pendapatan|Fennec Pharmaceuticals - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan HRTX (Heron Therapeutics Inc)|Nuvectis - Multiplikator EV/Sales|Nilai bisnis marang pendapatan CHRS (Coherus BioSciences Inc.)|CRBP: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cardiff Oncology Corp (CRDF)|Rasio nilai perusahaan marang pendapatan BeyondSpring|BCAB: Nilai bisnis marang pendapatan|Multiplikator EV/Sales LIXT|Multiplikator EV/Sales Citius Pharmaceuticals Inc. (CTXR)|Rasio nilai perusahaan marang pendapatan Cellectar CLRB|BLRX (BioLineRx) - Nilai perusahaan marang volume dodolan|CANF: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan aprea.com|Kazia Therapeutics Limited (KZIA) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan NCNA|CMRX (Chimerix, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cyclacel Pharmaceuticals CYCC|G1 Therapeutics Inc. (GTHX) - Nilai bisnis marang pendapatan|KRON - Multiplikator nilai perusahaan marang pendapatan|Kintara Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan ONCT (Oncternal)|Portage Biotech Corp - Multiplikator EV/Sales